REGULATED PRESS RELEASE published on 12/22/2023 at 17:45, 11 months ago Eiffage and MAF2 align their governance agreements
REGULATED PRESS RELEASE published on 12/22/2023 at 08:30, 11 months ago Eiffage, Budimex and Rizzani de Eccher win in consortium the civil engineering and track-laying works of the 230-kilometre Latvian section of the Rail Baltica project
REGULATED PRESS RELEASE published on 12/18/2023 at 08:30, 11 months 4 days ago Eiffage wins in consortium the contract for a section of the line 15 East of the Grand Paris Express in a deal worth €2.54 billion
REGULATED PRESS RELEASE published on 11/08/2023 at 17:40, 1 year ago Financial information at 30 September 2023
REGULATED PRESS RELEASE published on 10/30/2023 at 18:05, 1 year ago Eiffage signs a real estate development contract with the Hérault ICC for the future Cambacérès campus in Montpellier
REGULATED PRESS RELEASE published on 10/26/2023 at 17:40, 1 year ago Eiffage, in consortium with Lorraine Énergie and DEF, carries out the work of the technical macro-lot for the restoration of Notre-Dame de Paris Cathedral
REGULATED PRESS RELEASE published on 10/25/2023 at 18:45, 1 year ago Eiffage strengthens its position in Getlink and crosses the threshold of 20% of the capital
REGULATED PRESS RELEASE published on 10/23/2023 at 17:40, 1 year ago Eiffage breaks ground on the future 25 000m2 oncology innovation-focused building for Kadans Science Partner on the Campus Grand Parc in Villejuif
REGULATED PRESS RELEASE published on 10/18/2023 at 17:40, 1 year 1 month ago Eiffage wins a contract to manufacture 76 transition pieces for Baltic Power, Poland’s first offshore wind farm
REGULATED PRESS RELEASE published on 10/17/2023 at 17:40, 1 year 1 month ago Eiffage is pursuing its growth strategy in Europe with the acquisition in Germany of Salvia Group GmbH in the energy field
Published on 11/22/2024 at 16:00, 1 hour 53 minutes ago Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 1 hour 58 minutes ago Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 2 hours 38 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 3 hours 8 minutes ago Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 14:30, 3 hours 23 minutes ago Allied Universal Named Presenting Sponsor of 2024 Lott IMPACT Trophy Recognizing College Football's Defensive Best
Published on 11/22/2024 at 16:00, 1 hour 52 minutes ago Proposed cancellation of admission to trading
Published on 11/22/2024 at 16:00, 1 hour 53 minutes ago AlphaX Makes Crypto Easier with Email Login and USDT Memecoins
Published on 11/22/2024 at 15:27, 2 hours 26 minutes ago EQS-Adhoc: Eckert & Ziegler raises its forecast for the current financial year once again
Published on 11/22/2024 at 14:46, 3 hours 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 06:58, 1 day 10 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 22 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024